SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Pharmagreen Biotech Inc. (PHBI) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 26/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PHBI
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio232.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2008 |
$-0.02 |
$0.00 |
$-1.67K |
- |
| 2009 |
$-0.26 |
$0.00 |
$-69.68K |
- |
| 2017 |
$-0.07 |
$0.00 |
$-18.99K |
- |
| 2018 |
$-0.04 |
$0.00 |
$-1.07M |
- |
| 2019 |
$-0.01 |
$0.00 |
$-768K |
- |
| 2020 |
$-0.03 |
$0.00 |
$-2.44M |
- |
| 2021 |
$-0.02 |
$0.00 |
$-4.53M |
- |
| 2022 |
$0.00 |
$0.00 |
$-875K |
- |
| 2023 |
$0.00 |
$3K |
$-569K |
-18979.3% |
| 2024 |
$0.00 |
$3.41K |
$-1M |
-29442.8% |
